Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Zijlker LP, Chen H, Spillane AJ, Gonzalez M, Pennington TE, Menzies AM, Lo SN, Ferguson P, Rawson R, Colebatch AJ, Stretch JR, Thompson JF, Ch'ng S, Nieweg O, Shannon KF, Long GV, Scolyer RA, Saw RPM, van Akkooi ACJ. Zijlker LP, et al. Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15274-0. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38762644
ASO Visual Abstract: The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma: An Australian Cohort.
Zijlker LP, Chen H, Spillane AJ, Gonzalez M, Pennington TE, Menzies AM, Lo SN, Ferguson P, Rawson R, Colebatch AJ, Stretch JR, Thompson JF, Ch'ng S, Nieweg O, Shannon KF, Long GV, Scolyer RA, Saw RPM, van Akkooi ACJ. Zijlker LP, et al. Ann Surg Oncol. 2024 May 17. doi: 10.1245/s10434-024-15348-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38758487 No abstract available.
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.
Menzies AM, Lo SN, Saw RPM, Gonzalez M, Ch'ng S, Nieweg OE, Shannon KF, Ferguson PM, Lee J, Emmett L, Kapoor R, Rawson RV, Stretch JR, Thompson JF, Spillane AJ, Rizos H, Scolyer RA, Long GV. Menzies AM, et al. Ann Oncol. 2024 May 14:S0923-7534(24)00141-8. doi: 10.1016/j.annonc.2024.05.002. Online ahead of print. Ann Oncol. 2024. PMID: 38754780
Re: Vangipuram et al.: Timing of delayed retinal pathology in patients presenting with acute posterior vitreous detachment in the IRIS registry (Intelligent Research in Sight). (Ophthalmol Ret. 2023:7:713-720).
Gallo B, Jalil A, Hillier RJ, Costen M, Sandinha MT, Steel DH, Winder S, Ch'ng SW, Saidkasimova S, Charles S, Chandra A. Gallo B, et al. Ophthalmol Retina. 2024 May 6:S2468-6530(24)00173-8. doi: 10.1016/j.oret.2024.03.023. Online ahead of print. Ophthalmol Retina. 2024. PMID: 38727670 No abstract available.
Neuroanatomical distribution of fluorophores within adult RXFP3 Cre-tdTomato/YFP mouse brain.
Eraslan IM, Egberts-Brugman M, Read JL, Voglsanger LM, Samarasinghe RM, Hamilton L, Dhar P, Williams RJ, Walker LC, Ch'ng S, Lawrence AJ, Walker AJ, Dean OM, Gundlach AL, Smith CM. Eraslan IM, et al. Biochem Pharmacol. 2024 May 5;225:116265. doi: 10.1016/j.bcp.2024.116265. Online ahead of print. Biochem Pharmacol. 2024. PMID: 38714277 Free article.
First Phase Development of a Patient-reported Outcome Measure for Midface Oncology.
Yung AE, Luong J, Crouch G, Hong AM, Ananda A, Taylor S, Kotronakis I, Low TH, Elliott MS, McBride K, Rutherford C, Clark JR, Ch'ng S. Yung AE, et al. Plast Reconstr Surg Glob Open. 2024 Mar 22;12(3):e5689. doi: 10.1097/GOX.0000000000005689. eCollection 2024 Mar. Plast Reconstr Surg Glob Open. 2024. PMID: 38525491 Free PMC article.
375 results